To study whether the overexpression of TSG101 is sufficient to initiate the formation of mammary cancer and to assess whether this oncoprotein is required for tumor maintenance, we generated transgenic mice that permit a tissue-specific and temporally controlled overexpression of TSG101 in the mammary epithelium. Here, TSG101 is linked to breast cancer.